Literature DB >> 24455485

Authors' reply: Serum Albumin for Tuberculosis in HIV Infected Patients Eligible for Antiretroviral Therapy.

Gerardo Alvarez-Uria1, Manoranjan Midde1, Raghavakalyan Pakam1, Praveen Kumar Naik1.   

Abstract

Entities:  

Year:  2013        PMID： 24455485      PMCID： PMC3892741          DOI： 10.5681/bi.2013.034

Source DB:  PubMed          Journal:  Bioimpacts        ISSN： 2228-5652


× No keyword cloud information.
  9 in total

1.  Commentary on: Serum Albumin for Tuberculosis in HIV Infected Patients Eligible for Antiretroviral Therapy.

Authors:  Viroj Wiwanitkit
Journal:  Bioimpacts       Date:  2013-12-02

2.  Association of serum albumin concentration with mortality, morbidity, CD4 T-cell reconstitution among tanzanians initiating antiretroviral therapy.

Authors:  Christopher R Sudfeld; Sheila Isanaka; Said Aboud; Ferdinand M Mugusi; Molin Wang; Guerino E Chalamilla; Wafaie W Fawzi
Journal:  J Infect Dis       Date:  2013-01-14       Impact factor: 5.226

3.  Serum albumin and short-term risk for mortality and cardiovascular disease among HIV-infected veterans.

Authors:  Joshua Lang; Rebecca Scherzer; Cristin C Weekley; Phyllis C Tien; Carl Grunfeld; Michael G Shlipak
Journal:  AIDS       Date:  2013-05-15       Impact factor: 4.177

Review 4.  Reassessment of albumin as a nutritional marker in kidney disease.

Authors:  Allon N Friedman; Stephen Z Fadem
Journal:  J Am Soc Nephrol       Date:  2010-01-14       Impact factor: 10.121

5.  Diagnostic and Prognostic Value of Serum Albumin for Tuberculosis in HIV Infected Patients Eligible for Antiretroviral Therapy: Datafrom an HIV Cohort Study in India.

Authors:  Gerardo Alvarez-Uria; Manoranjan Midde; Raghavakalyan Pakam; Praveen Kumar Naik
Journal:  Bioimpacts       Date:  2013-09-01

6.  Rapid Diagnosis of Pulmonary and Extrapulmonary Tuberculosis in HIV-Infected Patients. Comparison of LED Fluorescent Microscopy and the GeneXpert MTB/RIF Assay in a District Hospital in India.

Authors:  Gerardo Alvarez-Uria; Jose M Azcona; Manoranjan Midde; Praveen K Naik; Srinivasulu Reddy; Raghuprakash Reddy
Journal:  Tuberc Res Treat       Date:  2012-08-26

7.  Impact of Xpert MTB/RIF testing on tuberculosis management and outcomes in hospitalized patients in Uganda.

Authors:  Christina Yoon; Adithya Cattamanchi; J Lucian Davis; William Worodria; Saskia den Boon; Nelson Kalema; Winceslaus Katagira; Sylvia Kaswabuli; Cecily Miller; Alfred Andama; Heidi Albert; Pamela Nabeta; Christen Gray; Irene Ayakaka; Laurence Huang
Journal:  PLoS One       Date:  2012-11-06       Impact factor: 3.240

8.  Natural History and Factors Associated with Early and Delayed Mortality in HIV-Infected Patients Treated of Tuberculosis under Directly Observed Treatment Short-Course Strategy: A Prospective Cohort Study in India.

Authors:  Gerardo Alvarez-Uria; Praveen Kumar Naik; Raghavakalyan Pakam; Lakshminaryana Bachu; Manoranjan Midde
Journal:  Interdiscip Perspect Infect Dis       Date:  2012-12-18

9.  Time to treatment and patient outcomes among TB suspects screened by a single point-of-care xpert MTB/RIF at a primary care clinic in Johannesburg, South Africa.

Authors:  Colleen F Hanrahan; Katerina Selibas; Christopher B Deery; Heather Dansey; Kate Clouse; Jean Bassett; Lesley Scott; Wendy Stevens; Ian Sanne; Annelies Van Rie
Journal:  PLoS One       Date:  2013-06-06       Impact factor: 3.240
  9 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.